DAVITA INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net
DAVITA INC. (DVA) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net of $19.44 million for the 3-month period ending 2018-12-31, per its 10-K filed 2020-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss · last filed 2020-02-21
- DAVITA INC. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2018-12-31 was $19.44M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 3 month |
|---|---|
| 2018-12-31 | $19.44M 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |